|
Volumn 86, Issue 4, 2001, Pages 1119-1121
|
Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACTIVATED PROTHROMBIN COMPLEX;
ALPHA INTERFERON;
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 8 ANTIBODY;
CYCLOSPORIN;
D DIMER;
FIBRINOGEN;
FLUDARABINE;
PREDNISONE;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
RECOMBINANT BLOOD CLOTTING FACTOR 8;
ADULT;
ANTIBODY TITER;
BLEEDING;
CANCER;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CLINICAL ARTICLE;
CLINICAL FEATURE;
DIFFERENTIAL DIAGNOSIS;
DISSEMINATED INTRAVASCULAR CLOTTING;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
DRUG EFFECT;
DRUG EXPOSURE;
DRUG MECHANISM;
DRUG USE;
DRUG WITHDRAWAL;
FEMALE;
HEMOPHILIA A;
HUMAN;
LETTER;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
PROTHROMBIN TIME;
|
EID: 0034758419
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0037-1616545 Document Type: Letter |
Times cited : (29)
|
References (10)
|